Eton Pharmaceutical News

Eton Pharmaceuticals Analyst Ratings

BenzingaMay 6 12:39 ET

Eton Pharmaceuticals Analyst Ratings

BenzingaDec 11, 2023 06:42 ET

HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $10

BenzingaAug 11, 2023 07:06 ET

Eton Pharmaceuticals Analyst Ratings

BenzingaAug 11, 2023 07:05 ET

HC Wainwright Trims Price Target on Eton Pharmaceuticals to $9 From $10, Maintains Buy Rating

MT NewswiresJul 3, 2023 07:14 ET

HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Lowers Price Target to $9

BenzingaJul 3, 2023 06:11 ET

HC Wainwright & Co. Reiterates Buy on Eton Pharmaceuticals, Maintains $10 Price Target

BenzingaMar 21, 2023 06:21 ET

HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $10

Benzinga Real-time NewsSep 26, 2022 06:32 ET

Eton Pharmaceuticals Analyst Ratings

Benzinga Analyst RatingsSep 26, 2022 06:32 ET

HC Wainwright Adjusts Eton Pharmaceuticals' Price Target to $9 from $11, Keeps Buy Rating

MT NewswiresJul 25, 2022 10:47 ET

Eton Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow JonesJul 25, 2022 06:35 ET

Eton Pharmaceuticals Price Target Cut to $9.00/Share From $11.00 by HC Wainwright & Co.

Dow JonesJul 25, 2022 06:35 ET

Eton Pharmaceuticals analyst ratings

Benzinga Analyst RatingsJul 25, 2022 06:26 ET

HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Lowers Price Target to $9

Benzinga Real-time NewsJul 25, 2022 06:26 ET

B. Riley Trims Eton Pharmaceuticals' Price Target to $9 from $10 But Notes 'Solid' Growth Prospects Despite Partner Setback, Keeps Buy Rating

MT NewswiresJun 1, 2022 09:18 ET